In the News

November 18, 2011

Webcast: From the C-peptide symposium in Lisbon, Portugal September 12, 2011

Webcast: From the C-peptide symposium in Lisbon, Portugal September 12, 2011 more >>

September 07, 2011

Cebix to Chair Symposium on C-Peptide and the Pathophysiology of Diabetes at EASD

Cebix to Chair Symposium on C-Peptide and the Pathophysiology of Diabetes at European Association for the Study of Diabetes Annual Meeting 2011 more >>

August 18, 2011

Cebix is proud to announce our new Director of Finance and Controller, John Snyder

Cebix is proud to announce our new Director of Finance and Controller, John Snyder more >>

August 04, 2011

Cebix in BioWorld Today

BIOWORLD TODAY: Ersatta Shows Promise for Complications of Diabetes more >>

July 05, 2011

Cebix Poster Presentations for the American Diabetes Association

Cebix Poster Presentations for the American Diabetes Association more >>

June 24, 2011

Cebix’s Long-Acting C-Peptide ErsattaTM Has Potential in Multiple Chronic Complications of Diabete

Data for C-Peptide Replacement Therapy to Be Presented at 71st Annual Meeting of the American Diabetes Association more >>

June 16, 2011

Cebix Initiates Phase 1b Clinical Trial with Drug Candidate Ersatta

Company Addressing Chronic Complications of Diabetes with C-Peptide Replacement Therapy more >>

June 01, 2011

Cebix Announces Financial Advisor, Mr. John Crawford

Cebix Announces Financial Advisor, Mr. John Crawford more >>

May 11, 2011

Cebix is proud to announce our new Chief Medical Officer, Howard Foyt.

Cebix is proud to announce our new Chief Medical Officer, Howard Foyt. more >>

February 11, 2011

Cebix is proud to announce our new Clinical Trial Manager, Mark Daniels.

Cebix is proud to announce our new Clinical Trial Manager, Mark Daniels. more >>

January 19, 2011

Cebix is proud to announce a new Senior Vice President of Pharmaceutical Development

Cebix is proud to announce a new Senior Vice President of Pharmaceutical Development more >>

October 18, 2010

A Sweet Life: The Source for the Healthy Diabetic asks Cebix, “Is Insulin Enough?“

Since insulin was first given to diabetics in the 1920s, it has been cast as the magical elixir of type 1 diabetes. As far as the big picture goes, it is, since it keeps those of us without healthy beta cells from dying. As diabetes care advances, how more >>

October 15, 2010

Jim Callaway to present at OMICS’s International Conference on Diabetes & Metabolism

International Conference on Diabetes & Metabolism more >>

September 28, 2010

Cebix Presents at Sofinnova Japan

Cebix Presents at Sofinnova Japan more >>

September 27, 2010

Cebix presents at the 46th Annual Meeting of the European Association for the Study of Diabetes

Cebix presents at the 46th Annual Meeting of the European Association for the Study of Diabetes more >>

July 24, 2010

Dr. John Wahren and Jim Callaway to present at the annual meeting of Neurodiab

Dr. John Wahren and Jim Callaway to present at the annual meeting of Neurodiab more >>

July 22, 2010

Dr. John Wahren to present at Nobel Forum, Karolinska Institutet, Stockholm

Dr. John Wahren to present at Nobel Forum, Karolinska Institutet, Stockholm more >>

June 18, 2010

2010 JDRF Walk to Cure Diabetes

Cebix proudly supports the 2010 JDRF Walk to Cure Diabetes more >>

May 26, 2010

11th Annual JDRF Promise Ball raises over $745,000 for Diabetes Research

11th Annual JDRF Promise Ball raises over $745,000 for Diabetes Research more >>

November 09, 2009

Cebix Proudly Supports the 2009 JDRF Walk to Cure Diabetes

2009 JDRF Walk to Cure Diabetes more >>